Close Menu

NEW YORK – BC Platforms said today that it has entered into a collaboration with Finnish company Blueprint Genetics to develop data-driven clinical genetic testing services for patients with rare diseases.

The partners will combine Blueprint Genetics' clinical genetic testing services with BC Platforms' data management technology to help hospital systems and life sciences companies incorporate large genetic datasets into patient care, research studies, and sponsored testing programs, they said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.